GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone
- PMID:24814730
- DOI: 10.1016/j.neuroscience.2014.04.037
GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone
Abstract
Interactions between neurotransmitters and the immune system represent new prospects for understanding neuroinflammation and associated neurological disease. GABA is the chief inhibitory neurotransmitter but its actions on immune pathways in the brain are unclear. In the present study, we investigated GABAergic transport in conjunction with neuroinflammation in models of multiple sclerosis (MS). Protein and mRNA levels of γ-amino butyric acid transporter 2 (GAT-2) were examined in cerebral white matter from MS and control (Non-MS) patients, in cultured human macrophages, microglia and astrocytes, and in spinal cords from mice with and without experimental autoimmune encephalomyelitis (EAE) using western blotting, immunocytochemistry and quantitative real-time polymerase chain reaction (qRT-PCR). GABA levels were measured by HPLC. The GAT-2's expression was increased in MS patients' (n=6) white matter, particularly in macrophage lineage cells, compared to Non-MS patients (n=6) (p<0.05). Interferon-γ (IFN-γ) stimulation of human macrophage lineage cells induced GAT-2 expression and reduced extracellular GABA levels (p<0.05) but soluble GABA treatment suppressed HLA-DRα, GAT-2 and XBP-1/s expression in stimulated macrophage lineage cells (p<0.05). Similarly, the synthetic allopregnanolone analog, ganaxolone (GNX), repressed GAT-2, JAK-1 and STAT-1 expression in activated macrophage lineage cells (p<0.05). In vivo GNX treatment reduced Gat-2, Cd3ε, MhcII, and Xbp-1/s expression in spinal cords following EAE induction (p<0.05), which was correlated with improved neurobehavioral outcomes and reduced neuroinflammation, demyelination and axonal injury. These findings highlight altered GABAergic transport through GAT-2 induction during neuroinflammation. GABA transport and neuroinflammation are closely coupled but regulated by GNX, pointing to GABAergic pathways as therapeutic targets in neuroinflammatory diseases.
Keywords: experimental autoimmune encephalitis; ganaxolone; multiple sclerosis; neuroinflammation; γ-amino butyric acid; γ-amino butyric acid transporter-2.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.
Similar articles
- Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.Rahimi A, Faizi M, Talebi F, Noorbakhsh F, Kahrizi F, Naderi N.Rahimi A, et al.Neuroscience. 2015 Apr 2;290:279-87. doi: 10.1016/j.neuroscience.2015.01.030. Epub 2015 Jan 28.Neuroscience. 2015.PMID:25637488
- Characteristic development of the GABA-removal system in the mouse spinal cord.Kim J, Kosaka Y, Shimizu-Okabe C, Niizaki A, Takayama C.Kim J, et al.Neuroscience. 2014 Mar 14;262:129-42. doi: 10.1016/j.neuroscience.2013.12.066. Epub 2014 Jan 9.Neuroscience. 2014.PMID:24412234
- Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C.Noorbakhsh F, et al.J Exp Med. 2006 Feb 20;203(2):425-35. doi: 10.1084/jem.20052148. Epub 2006 Feb 13.J Exp Med. 2006.PMID:16476770Free PMC article.
- Neuronal injury in chronic CNS inflammation.Zindler E, Zipp F.Zindler E, et al.Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29.Best Pract Res Clin Anaesthesiol. 2010.PMID:21619866Review.
- IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis.Mandolesi G, Gentile A, Musella A, Centonze D.Mandolesi G, et al.Cerebellum. 2015 Feb;14(1):19-22. doi: 10.1007/s12311-014-0613-0.Cerebellum. 2015.PMID:25326653Review.
Cited by
- Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.Noorbakhsh F, Baker GB, Power C.Noorbakhsh F, et al.Front Cell Neurosci. 2014 Jun 3;8:134. doi: 10.3389/fncel.2014.00134. eCollection 2014.Front Cell Neurosci. 2014.PMID:24917787Free PMC article.Review.
- Immunomodulatory Effect of Toll-Like Receptor-3 Ligand Poly I:C on Cortical Spreading Depression.Ghaemi A, Sajadian A, Khodaie B, Lotfinia AA, Lotfinia M, Aghabarari A, Khaleghi Ghadiri M, Meuth S, Gorji A.Ghaemi A, et al.Mol Neurobiol. 2016 Jan;53(1):143-154. doi: 10.1007/s12035-014-8995-z. Epub 2014 Nov 23.Mol Neurobiol. 2016.PMID:25416860
- Understanding the function of the GABAergic system and its potential role in rheumatoid arthritis.Shan Y, Zhao J, Zheng Y, Guo S, Schrodi SJ, He D.Shan Y, et al.Front Immunol. 2023 Feb 7;14:1114350. doi: 10.3389/fimmu.2023.1114350. eCollection 2023.Front Immunol. 2023.PMID:36825000Free PMC article.Review.
- Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury.Verdoorn TA, Parry TJ, Pinna G, Lifshitz J.Verdoorn TA, et al.Neurotherapeutics. 2023 Oct;20(6):1603-1615. doi: 10.1007/s13311-023-01428-7. Epub 2023 Aug 31.Neurotherapeutics. 2023.PMID:37653253Free PMC article.Review.
- Dynamical changes in the expression of GABAergic and purinergic components occur during the polarization of THP-1 monocytes to proinflammatory macrophages.Ruiz-Rodríguez VM, Torres-González CA, Salas-Canedo KM, Pecina-Maza NQ, Martínez-Leija ME, Portales-Pérez DP, Estrada-Sánchez AM.Ruiz-Rodríguez VM, et al.Biochem Biophys Rep. 2023 Oct 18;36:101558. doi: 10.1016/j.bbrep.2023.101558. eCollection 2023 Dec.Biochem Biophys Rep. 2023.PMID:37881409Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous